Le Mercier et al. presented that anti-VISTA mAb administration restricts the emergence and the suppressive potential of Tregs, increases the infiltration and effector function of CD8+T-cells in the TME, and suppresses the growth of melanoma in mice [117]. The gene discussed is VSIR; the disease is melanoma.